Skip to content

Lower Protein Intake and Long-term Risk of Obesity and Cardiovascular Disease

Lower Protein Intake and Long-term Risk of Obesity and Cardiovascular Disease: A Multi-centred, Randomised, Controlled Trial

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03456934
Acronym
BabyGrowth
Enrollment
249
Registered
2018-03-07
Start date
2017-08-07
Completion date
2022-10-13
Last updated
2023-03-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Infant Formula, Growth

Keywords

Protein requirements, Adiposity, Body composition, Cardiovascular health

Brief summary

The primary objective of this study is to investigate if consumption of lower protein formula can slow the rate of weight gain of formula-fed infants between 3 and 12 months of age. Secondary objectives include investigation into whether infant nutrition and growth have an impact on later risk of obesity and cardiovascular disease.

Detailed description

Obesity and its cardiovascular consequences are the most important causes of morbidity and mortality worldwide. Breastfed infants have been shown to have less cardiovascular risk factors in adulthood, which can be partially explained by their slower growth compared to formula fed infants. The primary objective of this study is to investigate if consumption of lower protein formula can slow the rate of weight gain of formula-fed infants between 3 and 12 months of age. Secondary objectives include investigation into whether infant nutrition and growth have an impact on later risk of obesity and atherosclerotic cardiovascular disease (CVD), the critical windows for these programming effects, and the mechanisms of action.

Interventions

Test formula with lower protein content than standard formula

Standard infant formula

Sponsors

University College, London
CollaboratorOTHER
Société des Produits Nestlé (SPN)
Lead SponsorINDUSTRY

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
OTHER
Masking
QUADRUPLE (Subject, Caregiver, Investigator, Outcomes Assessor)

Intervention model description

Prospective, randomized, double-blind with nonrandomized breast-fed reference group

Eligibility

Sex/Gender
ALL
Age
13 Weeks to 15 Weeks
Healthy volunteers
Yes

Inclusion criteria

* Healthy term infant * Infant is aged 14 weeks (+/- 1 week) * Infant is exclusively formula feeding or predominantly breast-feeding at age 14 weeks

Exclusion criteria

* Any adverse maternal, fetal or infant medical history that may have effects on growth and/or development * Infant born with congenital disease or malformation affecting growth and/or development * Food allergy to any trial products (e.g. milk, soy)

Design outcomes

Primary

MeasureTime frameDescription
Infant weight gainBetween ages 14 weeks (+/- 1 week) and 12 months (+/- 2 weeks)Rate of weight gain (g/d)

Secondary

MeasureTime frameDescription
Fat massAge 2 years (+/- 1 month)Deuterium dilution (assessed in subset)
Body mass index (BMI)-for-age Z-scoreAge 2 years (+/- 1 month)Based on World Health Organization (WHO) growth standards
Height-for-age Z-scoreAge 2 years (+/- 1 month)Based on WHO growth standards
AdiposityAge 2 years (+/- 1 month)Sum of 4 skinfolds (triceps, biceps, sub-scapular, supra-iliac)

Other

MeasureTime frameDescription
Head circumferenceAges 4, 5, 6, 12 and 24 monthsHead circumference (cm)
Body mass indexAges 6, 12 and 24 monthsWeight and length or height will be combined to report BMI in kg/m\^2
Weight-for-age Z-scoreAges 14 weeks and 4, 5, 6, 12 and 24 monthsBased on WHO growth standards
Weight-for-length Z-scoreAges 14 weeks and 4, 5, 6, 12 and 24 monthsBased on WHO growth standards
Height-for-age Z-scoreAges 14 weeks and 4, 5, 6, and 12 monthsBased on WHO growth standards
Blood pressureAt age 12 and 24 monthsSystolic and diastolic blood pressure (in a subset)
Adverse eventsAges 14 weeks and 4, 5, 6, 9, 12 and 24 monthsSafety
Feeding intakeAges 14 weeks and 4, 5, 6, and 12 monthsInfant feeding questionnaire
Feeding toleranceAges 14 weeks and 4, 5, 6, and 12 monthsGI symptom and stool pattern questionnaire
Metabolic markers of cardiovascular healthAges 6 and 12 monthsBlood sample (in a subset)
BMI-for-age Z-scoreAges 14 weeks and 4, 5, 6, and 12 monthsBased on WHO growth standards
Appetite and feeding / eating behaviorAges 14 weeks and 4, 5, 6, and 24 monthsBaby and Children's Eating Behavior Questionnaire
Infant weight gainBetween 6 and 12 monthsRate of weight gain (g/d)
WeightAges 4, 5, 6, 12 and 24 monthsBody weight (kg)
Length or heightAges 4, 5, 6, 12 and 24 monthsLength or height (cm)

Countries

United Kingdom

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026